Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis

Version 2 2020-04-02, 10:57

Version 1 2020-03-11, 14:32

figure

posted on 2020-04-02, 10:57 authored by Miao Yu, Guo Yue Yuan, Bin Zhang, Hai Ya Wu, Xiao Feng Lv

The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

Usage metrics

Keywords

Baseline HbA1c Dulaglutide Glimepiride Hypoglycemia Insulin glargine Type 2 diabetes mellitus

Licence

CC BY-NC 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM